About the Company
We do not have any company description for XOMA Corp at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $XOMA News
XOMA Corp - 8.375% DP PFD B declares $0.5234 dividend
XOMA Corp - 8.375% DP PFD B (NASDAQ:XOMAO) declares $0.5234/share quarterly dividend, in line with previous. Forward yield ...
XOMA Corporation Announces Closing of Tender Offer
EMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping ...
Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
Friday, XOMA Corporation (NASDAQ:XOMA) agreed to acquire Kinnate Biopharma Inc (NASDAQ:KNTE) for a base cash price of $2.3352 ...
XOMA Corp XOMA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Xoma: Q4 Earnings Snapshot
EMERYVILLE, Calif. — EMERYVILLE, Calif. — Xoma Corp. (XOMA) on Friday reported a loss of $21.5 million in its fourth quarter. On a per-share basis, the Emeryville, California-based company ...
XOMA to Present at Upcoming Investor Conferences in March
EMERYVILLE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the ...
XOMA Corporation
XOMA CORP's gross profit margin for the third quarter of its fiscal year 2023 has significantly increased when compared to the same period a year ago. Even though sales increased, the net income ...
XOMA Corp X0M1
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
XOMA Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...